205 related articles for article (PubMed ID: 16607116)
1. Anticatabolic properties of melanocortin-4 receptor antagonists.
Madison LD; Marks DL
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):196-200. PubMed ID: 16607116
[TBL] [Abstract][Full Text] [Related]
2. MC4 receptor antagonists: a potential treatment for cachexia.
Foster AC; Chen C; Markison S; Marks DL
IDrugs; 2005 Apr; 8(4):314-9. PubMed ID: 15800806
[TBL] [Abstract][Full Text] [Related]
3. Cachexia: lessons from melanocortin antagonism.
Deboer MD; Marks DL
Trends Endocrinol Metab; 2006 Jul; 17(5):199-204. PubMed ID: 16750633
[TBL] [Abstract][Full Text] [Related]
4. Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease.
DeBoer MD; Marks DL
Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):459-66. PubMed ID: 16932335
[TBL] [Abstract][Full Text] [Related]
5. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
6. Recently identified peptides involved in the regulation of body weight.
Bessesen DH; Faggioni R
Semin Oncol; 1998 Apr; 25(2 Suppl 6):28-32. PubMed ID: 9625380
[TBL] [Abstract][Full Text] [Related]
7. Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice.
Nicholson JR; Kohler G; Schaerer F; Senn C; Weyermann P; Hofbauer KG
J Pharmacol Exp Ther; 2006 May; 317(2):771-7. PubMed ID: 16436498
[TBL] [Abstract][Full Text] [Related]
8. Cachexia and obesity: two sides of one coin?
Inui A; Meguid MM
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):395-9. PubMed ID: 12806212
[TBL] [Abstract][Full Text] [Related]
9. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
10. Melanocortin-4 receptor in sheep: a potential site for therapeutic intervention in disease models.
Sartin JL; Wagner CG; Marks DL; Daniel JA; McMahon CD; Obese FY; Partridge C
Domest Anim Endocrinol; 2005 Aug; 29(2):446-55. PubMed ID: 15919173
[TBL] [Abstract][Full Text] [Related]
11. Melanocortin interventions in cachexia: how soon from bench to bedside?
DeBoer MD
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):457-62. PubMed ID: 17563464
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss.
Li G; Zhang Y; Rodrigues E; Zheng D; Matheny M; Cheng KY; Scarpace PJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E252-8. PubMed ID: 17389713
[TBL] [Abstract][Full Text] [Related]
13. The neuronal histamine H(1) and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure.
Yoshimatsu H
Peptides; 2006 Feb; 27(2):326-32. PubMed ID: 16343692
[TBL] [Abstract][Full Text] [Related]
14. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
[TBL] [Abstract][Full Text] [Related]
15. Anatomy and regulation of the central melanocortin system.
Cone RD
Nat Neurosci; 2005 May; 8(5):571-8. PubMed ID: 15856065
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic pathways converge upon central melanocortin systems to regulate energy balance.
Zhou L; Williams T; Lachey JL; Kishi T; Cowley MA; Heisler LK
Peptides; 2005 Oct; 26(10):1728-32. PubMed ID: 15993514
[TBL] [Abstract][Full Text] [Related]
17. Histamine and the regulation of body weight.
Jørgensen EA; Knigge U; Warberg J; Kjaer A
Neuroendocrinology; 2007; 86(3):210-4. PubMed ID: 17848791
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism.
Proneth B; Xiang Z; Pogozheva ID; Litherland SA; Gorbatyuk OS; Shaw AM; Millard WJ; Mosberg HI; Haskell-Luevano C
Chem Biol Drug Des; 2006 Mar; 67(3):215-29. PubMed ID: 16611215
[TBL] [Abstract][Full Text] [Related]
19. Role of the central melanocortin system in cachexia.
Marks DL; Ling N; Cone RD
Cancer Res; 2001 Feb; 61(4):1432-8. PubMed ID: 11245447
[TBL] [Abstract][Full Text] [Related]
20. Influence of ghrelin on food intake and energy homeostasis.
De Vriese C; Delporte C
Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):615-9. PubMed ID: 17693746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
